Aubree Gordon is an Associate Professor of Epidemiology who specializes in large studies to examine susceptibility to and transmission of respiratory viruses.
Virginia Pierce is an Associate Professor of Microbiology who specializes in improving the accuracy and speed with which clinical microbiology laboratories can characterize the susceptibility profile of pathogens and use this information to advise clinicians about the selection of effective, targeted antimicrobial therapy.
Carmen Gherasim is an Assistant Professor of Pathology in the Department of Pathology at Michigan Medicine.
David Manthei is an Assistant Professor of Pathology and serves as Associate Director of the Immunology and Special Chemistry laboratories.
Emily Stoneman is an Associate Professor of Infectious Diseases in the Department of Internal Medicine and serves as the Medical Director of Occupational Health Services.
Dr. Yoshihiro Kawaoka established the technique of reverse genetics, which allows the generation of ‘designer’ influenza viruses. This technology was used to develop the flu vaccine FluMist® and candidate bird flu vaccines. Dr. Kawaoka also studies Ebola virus pathogenesis and is currently developing an Ebola vaccine, which entered clinical trials in 2019. In February 2020, he began a SARS-CoV-2 research program that includes establishing animal models of infection and developing safe and effective vaccines.
Theresa Kowalski-Dobson, MPH
Theresa is the program manager for the IASO study.
Noah Paalanen
Noah is a study coordinator and data manager for the VIVA and FluGuardians studies.